Skip to main content
SpringerLink
Log in

Selenium in chronic neurologic diseases

Multiple sclerosis and Batten’s disease

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

The selenium levels in whole blood and the activity of glutathione peroxidase in hematogenous cells of normal Danes have been defined taking into account sex and confounding factors such as smoking and aging. No differences related to sex could be found with regard to the selenium level, and peroxidase activity assayed with hydrogen peroxide. However, the peroxidase activity assayed with t-butyl hydroperoxide was higher in females than in males (p<.05). The peroxidase activities are dependent on age. Thus, the peroxidase levels assayed with both substrates show a minimum value in the age group from 40 to 50 yr for both smokers and nonsmokers. Smokers did show more homogeneous values as a function of age than nonsmokers. Smokers had significantly lower selenium values than nonsmokers, but glutathione peroxidase values identical with those of nonsmokers. Multiple sclerosis (MS) patients suffer from a chronic relapsing/remitting demyelinating disease. A theory explaining the pathogenesis of MS concerns increased stickiness of cellular plasma membranes, hampering normal vascular function of the brain. In agreement with that theory, the present communication demonstrates significantly lowered selenium values and lowered glutathione peroxidase activities of major types of hematogenous cells. In close agreement with these findings, hematogenous cells in MS show increased peroxidation rates. A nonblinded biochemical dietary experiment on MS patients showed that all abnormalities could be normalized by daily intake of selenium, vitamin E, and vitamin C.

Batten’s disease is a recessive inherited neurodegenerative disorder clinically characterized by progressive loss of vision, epilepsy, and dementia. Neuropathologically, this disease is characterized by storage of lipofuscin in nervous tissue. We have in a few cases documented a low selenium status and low glutathione peroxidase activities of hematogenous cells. As in MS, we normalized the biochemical abnormalities by an antioxidative treatment. Like in similar Finnish studies, the biochemical parameters can be normalized. Further, the Finnish studies indicate it possible by an antioxidative treatment to inhibit progression of the mental deterioration.

The data presented will be discussed in relationship both to specific pathological parameters of the diseases and to the low dietary energy expenditures of handicapped immobile patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. J. Clausen, and J. Jensen,Ugeskr. f.Laeger 37, 2155–2162, 1975.

    Google Scholar 

  2. B. Borgstrom, I. Dencker, and Å. Norden,Lækartidn. 67, 3678, 1970.

    Google Scholar 

  3. K. Schwarz, and C. M. Foltz,J. Am. Chem. Soc. 79, 3292, 1957.

    Article  CAS  Google Scholar 

  4. C. F. Combs, and S. B. Combs,Ann. Rev. Biochem. 4, 257–280, 1984.

    CAS  Google Scholar 

  5. H. Mickel,Perspectives Biol. Med. 18, 363–374 (1975).

    CAS  Google Scholar 

  6. R. H. S. Thompson,Biochem. Soc. Symp. no 35, Ganguly, J. and Smellie, eds., Academic, London, 1972.

    Google Scholar 

  7. G. E. Jensen and J. Clausen, Glutathione Peroxidase activities in leukocytes, erythrocytes and serum from juvenile form of neuronal lipofuscinosis, inCeroid-lipofuscinosis (Batten’s disease), Armstrong, D., Koppang, N., and Rider, J. A., eds., 1982.

  8. G. E. Jensen, and J. Clausen,Scand. J. Clin. Lab. Invest. 38, 309–318, 1978.

    Article  PubMed  CAS  Google Scholar 

  9. L. S. Wolfe, Ng, N. M. K., Y. Kin, and R. R. Baker, Batten’s disease and related disorders: New findings on the chemistry of the storage material, in,Lysosomes and lysosomal storage diseases, Callahan, J. W. and Lowden, J. A., eds., Raven, New York, 1981, pp. 311–330.

    Google Scholar 

  10. G. A. Schumacher, G. Bebee, R. F. Kilber et al.Ann. NY Acad. Sci. 122, 552–565, 1965.

    Google Scholar 

  11. T. Westermarck, and M. Sandholm,Acta pharmacol. et Toxicol. 40, 70–74, 1977.

    CAS  Google Scholar 

  12. P. Santavouri, T. Westermarck, J. Rapola, P. Rohja, R. Moren, Lappi, M., and U. Vuonnala,Acta Neurol. Scand. 71, 136–145, 1985.

    Google Scholar 

  13. E. Beutler, K. G. Blume, J. C. Kaplan, G. W. Loehr, B. Ramot, and W. N. Valentine, W. N.,Brit. J. Haematol. 35, 331–340, 1977.

    Article  CAS  Google Scholar 

  14. D. E. Paglia, and W. N. Valentine,J. Lab. Clin. Med. 70, 158, 1970.

    Google Scholar 

  15. G. E. Jensen, and J. Clausen,Scand. J. Clin. Lab. Invest. 43, 187–196, 1983.

    Article  PubMed  CAS  Google Scholar 

  16. T. W. Kwon, and B. M. Watts,J. Food Sci. 28, 627, 1963.

    Article  CAS  Google Scholar 

  17. E. B. Thorling, K. Overvad, and J. Geboers,Ann. Clin. Res. 18, 3–7, 1986.

    PubMed  CAS  Google Scholar 

  18. S. Rastogi, J. Clausen, and K. C. Scrivastava,Toxicol. 6, 377–388, 1976.

    Article  CAS  Google Scholar 

  19. M. Chiba, N. Fujimoto, N. Oyamada, and M. Kikichi,Biol. Trace Element Res. 8, 263–282, 1984.

    Article  Google Scholar 

  20. G. Ohi, S. Nishigaki, H. Seki, Y. Tamura, T. Maki, H. Meada, S. Ochiai, H. Yamada, Y. Shimamura, and H. Yagyu,Toxicol. Appl. Pharmacol.,32, 527–533, 1975.

    Article  CAS  Google Scholar 

  21. O. A. Levander,Fed. Proc. 44, 2579–2583, 1985.

    PubMed  CAS  Google Scholar 

  22. C. Clark,L. Fed. Proc. 44, 2584–2589, 1985.

    CAS  Google Scholar 

  23. J. T. Salonen, R. Salonen, R. Lappetelainen, P. Måenpaa, G. Alfta, and P. Puska,Brit. Med. J. 290, 417–420, 1984.

    Article  Google Scholar 

  24. R. J. Stead, L. J. Hinks, M. E. Hodson, A. N. Reddington, B. E. Clayton, and Batten, J. C.Lancet 2, 862–863, 1985.

    Article  PubMed  CAS  Google Scholar 

  25. W. Jubiz, and G. Nolan,Biochem. Biophys. Comm. 114, 855–862, 1983.

    Article  CAS  Google Scholar 

  26. H. Gyllenhammar, B. Ringertz, W. Becker, J. Svensson and J. Palmblad,Immunol. Letters 13, 185–189, 1986. Elsevier, 1982.

    Article  CAS  Google Scholar 

  27. J. Clausen,Acta Neurol. Scand. 70, 345–355, 1984.

    Article  PubMed  CAS  Google Scholar 

  28. L. J. Galland,Am. Coll. Nutr. 5, 213–228, 1986.

    CAS  Google Scholar 

  29. J. M. Bailey, R. W. Bryant, C. E. Low, M. B. Pupillo, and J. Y. Vanderhoek,Role of Lipoxygenase in Regulation of PHA and Phorbol Ester-Induced Mitogenesis: Leucotrienes and Other Lipoxygenase Products, B. Samuelsson, ed., Raven, New York, 1982, pp. 341–353.

    Google Scholar 

  30. A. S. Csallany, L.-C. Su,Scientif. J. Series Minnesota Agricultural Exp. Station paper no. 55108, 1984.

  31. J. J. Dougherty, and W. G. Hoekstra,Proc. Soc. Exp. Biol. Med. 169, 209–215. 1982.

    PubMed  CAS  Google Scholar 

  32. R. H. Dworkin,Lancet 1, 1153–1154, 1981.

    Article  PubMed  CAS  Google Scholar 

  33. G. N. Schrauzer, J. E. McGinness, and K. Kuehn,Caronogenesis (London),1, 199–201, 1980.

    CAS  Google Scholar 

  34. J. Clausen and J. Møller,Internat. Arch. Allergy 36, 224–233, 1969.

    Google Scholar 

  35. R. D. Jolly, A. Janmaat, D. M. West, and I. Morrison,Neuropath. Appl. Neurobiol. 6, 195–209, 1980.

    Article  CAS  Google Scholar 

  36. J. Miquel, K. G. Bensch, and J. E. Johnson, Lipofuscinosis: Fine structural and biochemical studies, in,Radicals in Biology, Pryor, W. A., ed., Academic, New York, 1977, pp. 133–182.

    Google Scholar 

  37. A. Tappel, B. Fletcher, and D. Deamer,J. Gerontol. 28, 415–424, 1973.

    PubMed  CAS  Google Scholar 

  38. H. Lal, S. Pogacar, P. Daly, and S. K. Puri, Behavioral and neuropathological manifestations of nutritionally induced central nervous system aging in the rat, in,Progr. Brain Res. 40, 129–140, 1973.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Institute for Life Sciences and Chemistry, University of Roskilde, DK 4000, Denmark

    Jørgen Clausen, Gunde Egeskov Jensen & Søren Achim Nielsen

Authors
  1. Jørgen Clausen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gunde Egeskov Jensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Søren Achim Nielsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clausen, J., Jensen, G.E. & Nielsen, S.A. Selenium in chronic neurologic diseases. Biol Trace Elem Res 15, 179–203 (1988). https://doi.org/10.1007/BF02990136

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02990136

Index Entries

Search

Navigation